US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 21.230
  • -0.230-1.07%
Trading Aug 12 10:52 ET
2.16BMarket Cap-3874P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday-0.62%
ARK Portfolio
ARK Portfolio
Intraday-1.07%